CHENGDU SHENG NUO BIOTEC CO., LTD.: Semi-annual Report for 2026
Filed with SSE · · 210 pages · Chinese
Cheng Du Sheng Nuo Biotec Co., Ltd. on 6ix
Story so far
Earlier from Cheng Du Sheng Nuo Biotec
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Convening the 2026 Semi-annual Performance Briefing
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on the Initial Grant of Restricted Shares to Participants
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on the Results of Shareholding Increase by the Controlling Shareholder and the Change in Shareholder Equity Reaching the 1% Threshold
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Review Opinion and Statement on the Public Disclosure of the List of Participants for the Initial Grant under the Company's 2026 Restricted Share Incentive Plan Issued by the Remuneration and Appraisal Committee of the Board of Directors
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Voluntary Disclosure of Semi-annual Performance Forecast for 2026
Later from Cheng Du Sheng Nuo Biotec
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Voluntary Disclosure of the Receipt of the Approval Notice for the Marketing Application of Terlipressin Acetate API
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Voluntary Disclosure of Obtaining Drug Registration Certificate for Linaclotide Capsules
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Progress of Shareholding Increase by Senior Management
- CHENGDU SHENG NUO BIOTEC CO., LTD.: Announcement on Voluntary Disclosure of Wholly-owned Subsidiary Obtaining the Drug Manufacturing License for New API Varieties and Passing the GMP Compliance Inspection
- (688117)"CHENGDU SHENG NUO BIOTEC CO., LTD."Announcement on Progress of Shareholding Increase by Senior Executive
Follow Cheng Du Sheng Nuo Biotec into a list and get an email when it puts out news.
Follow Cheng Du Sheng Nuo Biotec